Please assess the completion status of the following clinical trial:

Trial Title: Single Dose Monurol for Treatment of Acute Cystitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Non pregnant women in good health with symptoms of acute cystitis for less than 7 days~Exclusion Criteria:~* Pregnant, lactating, or not regularly contracepting~* History of chronic conditions such as diabetes~* Known anatomic abnormalities of the urinary tract~* Use of prophylactic antibiotics~* History of allergy or intolerance to any of the study drugs~* Recent (\> 2 weeks)exposure to oral or parenteral antimicrobial~* History of UTI in previous 1 month

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- TMP/SMX (Type: ACTIVE_COMPARATOR): Sulfamethoxazole-Trimethoprim 800-160 MG Oral Tab; 800mg/160mg BID x 3 days
- Fosfomycin (Type: EXPERIMENTAL): 3g sachet single dose

Based on this trial design, predict the completion outcome and termination type (if applicable).